Perrigo Company News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

24.10.19	Drug Companies Issue Recalls For Ranitidine, Zantac In US (RTTNews)
23.10.19	Perrigo Recalls Ranitidine Due To Possible Presence Of NDMA (RTTNews)
21.08.19	Perrigo Settles Patent Litigation On Generic Version Of Nascobal Nasal Spray (RTTNews)
08.08.19	Perrigo Reaffirms FY19 Adj. EPS Outlook - Quick Facts (RTTNews)
08.08.19	Perrigo Co. Q2 adjusted earnings Beat Estimates (RTTNews)
02.07.19	Perrigo Raises 2019 Adj. Profit View; Stock Up (RTTNews)
23.06.19	Perrigo Recalls Baby Formula Sold Only At Walmart Due To Metal Contamination (RTTNews)
09.05.19	Perrigo To Buy Privately-held Ranir Global Holdings For $750 Mln (RTTNews)
08.05.19	Perrigo Co. Q1 adjusted earnings Beat Estimates (RTTNews)
02.04.19	Perrigo Settles Patent Litigation For Generic Version Of Finacea Foam, 15% (RTTNews)
20.03.19	Perrigo Appoints Ray Silcock As CFO (RTTNews)
18.03.19	Perrigo Gets FDA Approval For Generic Version Of Finacea Foam (RTTNews)
27.02.19	Perrigo Company Q4 Earnings Miss Street (RTTNews)
27.02.19	Perrigo Co. Q4 adjusted earnings Miss Estimates (RTTNews)
25.02.19	Perrigo Files For Judicial Review On Irish Revenue Tax Assessment - Quick Facts (RTTNews)
26.12.18	Perrigo Shares Up 10% As Appeal Deadline For €1.6 Bln Irish Tax Bill Nears (RTTNews)
21.12.18	Perrigo Remains Sharply Lower After Early Sell-Off (RTTNews)
26.11.18	Perrigo Receives FDA's First To File Generic Version Of Ultravate Lotion (RTTNews)
09.11.18	MDXG Delisted, ENDP Boosts Outlook, AKAO Hits New Low, ReShape Deflated (RTTNews)
08.11.18	Perrigo Co. Q3 adjusted earnings Beat Estimates (RTTNews)
08.11.18	Perrigo Company Plc Updates Guidance - Quick Facts (RTTNews)
09.10.18	Perrigo Climbs Off Worst Levels But Remains Firmly Negative (RTTNews)
09.10.18	People In The News - Murray Kessler (RTTNews)
09.10.18	Perrigo Company Appoints Murray Kessler As CEO (RTTNews)
28.09.18	Perrigo Settles Patent Litigation On Generic Version Of Picato Gel (RTTNews)
07.09.18	Perrigo : FDA Oks Store Brand OTC Equivalent Of Imodium Multi-Symptom Relief (RTTNews)
09.08.18	Perrigo Profit Tops View, Cuts FY18 Forecast; Plans To Separate Rx Unit (RTTNews)
09.08.18	Perrigo Co. Q2 adjusted earnings Beat Estimates (RTTNews)
09.07.18	Hikma Pharma Signs Licensing, Distribution Agreement With Omega Pharma (RTTNews)
30.05.18	Perrigo to Present at the Jefferies 2018 Healthcare Conference (PR Newswire)
14.05.18	Perrigo Confirms First To File Patent Challenge For Generic Version Of Ultravate® Lotion, 0.05% (PR Newswire)
11.05.18	Perrigo Expects Complete Response Letter On Generic Version Of ProAir® (PR Newswire)
08.05.18	Perrigo Co. Q1 adjusted earnings of $1.26 per share (RTTNews)
08.05.18	Perrigo Co. Q1 Results Climb, Top Estimates; Backs FY18 Outlook - Quick Facts (RTTNews)
08.05.18	Perrigo Company plc Reports First Quarter 2018 Financial Results (PR Newswire)
03.05.18	Perrigo Announces Quarterly Dividend (PR Newswire)
28.04.18	Amneal And Impax Receive FTC Clearance For Business Combination (PR Newswire)
24.04.18	Perrigo To Release First Quarter Calendar Year 2018 Financial Results On May 8, 2018 (PR Newswire)
11.04.18	Perrigo Launches Novel Omeprazole Orally Disintegrating Tablet to Treat Frequent Heartburn (PR Newswire)
06.04.18	Impax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%) (PR Newswire)
07.03.18	Perrigo Announces Final FDA Approval and Planned Launch for the Store Brand OTC Equivalent of Mucinex® DM Maximum Strength Extended Release Tablets (PR Newswire)
07.03.18	Perrigo to Present at Upcoming Investor Conferences (PR Newswire)
01.03.18	Perrigo Co. Q4 Income Climbs (RTTNews)
01.03.18	Perrigo Files Form 10-K With SEC; Will Host Fourth Quarter And Calendar Year 2017 Financial Results Conference Call On March 2, 2018 (PR Newswire)
01.03.18	Perrigo Company plc Reports Fourth Quarter & Calendar Year 2017 Financial Results (PR Newswire)
27.02.18	Perrigo 2017 Net Sales Decline 6.3% - Quick Facts (RTTNews)
27.02.18	Perrigo Company plc Reports Select Preliminary Unaudited Calendar Year 2017 Financial Results (PR Newswire)
20.02.18	Perrigo Confirms Patent Challenge For Generic Version Of Finacea® Foam, 15% (PR Newswire)
20.02.18	Perrigo Names Ronald Winowiecki CFO - Quick Facts (RTTNews)
20.02.18	Perrigo Appoints Ronald L. Winowiecki as Chief Financial Officer (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Kuehne+Nagel Int	203.20	0.30 %	K V
Lonza Grp	541.20	-0.04 %	K V
Part Grp Hldg	1’266.50	-0.04 %	K V
Givaudan	4’058.00	-0.07 %	K V
Sonova Hldg	296.90	-0.13 %	K V
Roche Hldg G	256.00	-0.70 %	K V
Swiss Re	130.90	-0.80 %	K V
Sika	224.10	-0.93 %	K V
Nestle	74.40	-1.09 %	K V
UBS Group	27.83	-1.21 %	K V

mehr

21.10.24		S&P 500 aktuell: S&P 500 gibt nach
30.09.24		Handel in New York: S&P 500 fällt nachmittags
09.08.24		Freundlicher Handel: S&P 500 verbucht schlussendlich Zuschläge
09.08.24		Gewinne in New York: S&P 500-Börsianer greifen zu
09.08.24		Verluste in New York: S&P 500 fällt am Mittag zurück
06.08.24		Pluszeichen in New York: S&P 500 mittags fester
05.08.24		Handel in New York: S&P 500 verbucht schlussendlich Verluste
11.06.24		Pluszeichen in New York: S&P 500 legt schlussendlich zu

21.10.24

S&P 500 aktuell: S&P 500 gibt nach

30.09.24

Handel in New York: S&P 500 fällt nachmittags

09.08.24

Freundlicher Handel: S&P 500 verbucht schlussendlich Zuschläge

09.08.24

Gewinne in New York: S&P 500-Börsianer greifen zu

09.08.24

Verluste in New York: S&P 500 fällt am Mittag zurück

06.08.24

Pluszeichen in New York: S&P 500 mittags fester